Original articleAttitudes and practice in the management of metastatic colorectal cancer in Britain
References (16)
- et al.
Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases
Lancet
(1994) Evidence-based medicine: an incomplete method for informing treatment choices
Lancet
(1997)Factsheets 3.2–3.3 (UK cancer statistics)
(1995)- et al.
A randomized trial assessing the addition of interferon α2a to 5-fluorouracil and leucovorin in advanced colorectal cancer
J Clin Oncol
(1996) - et al.
Resection of colorectal liver metastases
World J Surg
(1995) - et al.
Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
BMJ
(1993) Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial
J Clin Oncol
(1992)- et al.
Fluorouracil + folates as standard treatment for advanced/metastatic gastrointestinal carcinomas [abstract]
Ann Oncol
(1994)
Cited by (54)
Pulmonary metastasectomy for colorectal cancer: Long-term survival and prognostic factors
2013, International Journal of SurgeryCitation Excerpt :More than half of all patients who undergo resection for colorectal carcinoma are expected to have recurrence of their disease, and the most frequent sites of distant recurrences are the liver and the lungs.1,2 Patients with untreated metastatic disease have a median survival of less than one-year and a five-year survival of less than 5%.3 Despite the development of novel chemotherapy and biological agents, surgery is still an important option for patients with pulmonary metastases.
Pulmonary metastases from colorectal cancer: Imaging findings and growth rates at follow-up CT
2012, Clinical ImagingCitation Excerpt :Pulmonary metastases develop in 5%–15% of all colorectal cancer (CRC) patients, and performing resection of the pulmonary metastases from CRC has yielded 5-year survival rates ranging from 20% up to 60% in several large series, while patients with untreated metastatic disease have 5-year survival rates of less than 5% [1,2].
Early intrapulmonary recurrence after pulmonary metastasectomy related to colorectal cancer
2010, Annals of Thoracic SurgeryPulmonary Resection for Metastases of Colorectal Adenocarcinoma
2010, Annals of Thoracic SurgeryPerimammary uniportal vats fissureless right anterior segmentectomy for lung metastasectomy: a case report
2023, Journal of Visualized Surgery